PortfoliosLab logo
Tools
Performance Analysis
Risk Analysis
Optimization
Factor Model
See All Tools
Portfolio Analysis
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
ABBV vs. JNJ
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Key characteristics


ABBVJNJ
YTD Return17.49%0.78%
1Y Return18.57%6.44%
3Y Return (Ann)24.40%1.05%
5Y Return (Ann)23.09%5.16%
10Y Return (Ann)18.26%7.78%
Sharpe Ratio1.020.35
Daily Std Dev18.68%15.65%
Max Drawdown-45.09%-50.68%
Current Drawdown-0.47%-10.78%

Fundamentals


ABBVJNJ
Market Cap$315.97B$374.07B
EPS$2.71$5.20
PE Ratio65.8529.85
PEG Ratio0.490.95
Revenue (TTM)$54.32B$85.16B
Gross Profit (TTM)$41.53B$63.95B
EBITDA (TTM)$26.36B$30.77B

Correlation

0.45
-1.001.00

The correlation between ABBV and JNJ is 0.45, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.

Performance

ABBV vs. JNJ - Performance Comparison

In the year-to-date period, ABBV achieves a 17.49% return, which is significantly higher than JNJ's 0.78% return. Over the past 10 years, ABBV has outperformed JNJ with an annualized return of 18.26%, while JNJ has yielded a comparatively lower 7.78% annualized return. The chart below displays the growth of a $10,000 investment in both assets, with all prices adjusted for splits and dividends.


200.00%300.00%400.00%500.00%600.00%700.00%OctoberNovemberDecember2024FebruaryMarch
714.91%
202.65%
ABBV
JNJ

Compare stocks, funds, or ETFs


AbbVie Inc.

Johnson & Johnson

Risk-Adjusted Performance

ABBV vs. JNJ - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Johnson & Johnson (JNJ). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratioSortino ratioOmega ratioCalmar ratioUlcer Index
ABBV
AbbVie Inc.
1.02
JNJ
Johnson & Johnson
0.35

ABBV vs. JNJ - Sharpe Ratio Comparison

The current ABBV Sharpe Ratio is 1.02, which is higher than the JNJ Sharpe Ratio of 0.35. The chart below compares the 12-month rolling Sharpe Ratio of ABBV and JNJ.


Rolling 12-month Sharpe Ratio-0.500.000.501.001.50OctoberNovemberDecember2024FebruaryMarch
1.02
0.35
ABBV
JNJ

Dividends

ABBV vs. JNJ - Dividend Comparison

ABBV's dividend yield for the trailing twelve months is around 3.32%, more than JNJ's 3.01% yield.


TTM20232022202120202019201820172016201520142013
ABBV
AbbVie Inc.
3.32%3.82%3.49%3.84%4.41%4.83%3.89%2.65%3.64%3.41%2.54%3.03%
JNJ
Johnson & Johnson
3.01%3.00%2.52%2.45%2.53%2.57%2.74%2.38%2.73%2.87%2.64%2.83%

Drawdowns

ABBV vs. JNJ - Drawdown Comparison

The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum JNJ drawdown of -50.68%. The drawdown chart below compares losses from any high point along the way for ABBV and JNJ


-20.00%-15.00%-10.00%-5.00%0.00%OctoberNovemberDecember2024FebruaryMarch
-0.47%
-10.78%
ABBV
JNJ

Volatility

ABBV vs. JNJ - Volatility Comparison

AbbVie Inc. (ABBV) has a higher volatility of 4.49% compared to Johnson & Johnson (JNJ) at 3.34%. This indicates that ABBV's price experiences larger fluctuations and is considered to be riskier than JNJ based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


3.00%4.00%5.00%6.00%7.00%OctoberNovemberDecember2024FebruaryMarch
4.49%
3.34%
ABBV
JNJ